Biotech

All Articles

IGM turns from cancer to autoimmune, agitating C-suite

.IGM Biosciences finished in 2014 giving up team as well as streamlining its cancer cells pipe. Righ...

Shattuck axes CD47 system over weak efficacy records, gives up 40% of workers and also sheds Ono deal

.Shattuck Labs has actually pounded one more nail right into the coffin of CD47. After viewing a "mo...

BioMarin goes Camping outdoors, striking RNA cope with biotech

.BioMarin is actually incorporating firewood to the R&ampD fire, hitting a suit with CAMP4 Rehabs fo...

Cash- strapped Gritstone starts look for calculated choices as cancer vaccination information underwhelm

.Gritstone bio has brought in bankers to explore "prospective value-maximizing methods" after its st...

Kailera launches with $400M series A, 4 Mandarin weight problems medicines

.Kailera Rehabs has actually launched in to the increasingly jampacked weight problems area along wi...

Metsera coordinate with Amneal to lock down GLP-1 supply

.Along with very early stage 1 data today out in bush, metabolic health condition outfit Metsera is ...

Rivus blog posts data to support muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually unveiled the information responsible for its period 2 obesity su...

BMS pays $110M to form T-cell treatment pact, assisting Perfect acquire time to develop prioritized pipe

.Bristol Myers Squibb is actually paying out Excellent Medication $110 thousand in advance to create...

Generate increases an additional $1B-plus Significant Pharma relationship

.Novartis has actually tattooed a bargain potentially worth greater than $1 billion with Flagship-fo...

Metsera GLP-1 information cut exposes 7.5% fat loss at 36 days

.Recently debuted Metsera is actually unfolding some phase 1 record for its GLP-1 receptor agonist, ...